Humanigen Inc (fka HGENQ)

[cowtown jay]

"(January 8, 2024, 6:35 PM EST) -- Biopharmaceutical company Humanigen Inc. received bankruptcy court approval Monday to access half of a $2 million debtor-in-possession loan to help fund its ongoing drug development operations and its Chapter 11 case."

https://www.google.com/search?q=Humanigen+Gets+Access+To+New+Cash+For+Ch.+11+Process&oq=Humanigen+Gets+Access+To+New+Cash+For+Ch.+11+Process&gs_lcrp=EgZjaHJvbWUyBggAEEUYOTIGCAEQRRg80gEJNTYxM2owajE1qAIAsAIA&sourceid=chrome&ie=UTF-8#ip=1

This hasn't stopped the Official Committee of Unsecured Creditors of Humanigen from hiring Kilpatrick Townsend & Stockton as co-counsel.

https://www.wsj.com/articles/firm-retention-summary-humanigen-9994dd15?utm_source=dlvr.it&utm_medium=twitter

Seems to me that the DIP Lender, and the Unsecured Creditors, both see some value.

Even more, it makes me wonder what drug development Durrant has keyed-in on at this particular point in time. Is this to support our partners in the PREACH-M trial, or the RATinG trial? It's a very positive sign of Durrant's continuing faith in lenzilumab.

Or, is Durrant's interest in promoting Ifab as an ADC, as shown on slide 3 of our Featured Presentation?

https://ir.humanigen.com/English/events-and-presentations/default.aspx

After all, CytoDyn recently announced that Glioblastoma was being targeted as a treatment candidate with their partners.